Related Stories



8 de May de 2023
Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…
Posted in: Parkinson

8 de May de 2023
The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…
Posted in: Parkinson

16 de January de 2023
On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…

3 de June de 2021
The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…
Posted in: Alzeimer, Uncategorised


8 de April de 2020
An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….
Posted in: Parkinson